Precision BioSciences, Inc. (DTIL)
7.29
-0.04
(-0.55%)
USD |
NASDAQ |
Jul 24, 16:00
7.30
+0.01
(+0.14%)
After-Hours: 20:00
Precision BioSciences EPS Diluted (Quarterly) : -0.7486 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.7486 |
| December 31, 2025 | 1.004 |
| September 30, 2025 | -1.842 |
| June 30, 2025 | -2.129 |
| March 31, 2025 | -2.213 |
| December 31, 2024 | -2.218 |
| September 30, 2024 | -2.254 |
| June 30, 2024 | 4.671 |
| March 31, 2024 | 1.696 |
| December 31, 2023 | -4.062 |
| September 30, 2023 | -4.304 |
| June 30, 2023 | -94.37 |
| March 31, 2023 | -6.755 |
| December 31, 2022 | -7.702 |
| September 30, 2022 | -6.481 |
| June 30, 2022 | -13.70 |
| Date | Value |
|---|---|
| March 31, 2022 | -13.85 |
| December 31, 2021 | -10.98 |
| September 30, 2021 | -5.672 |
| June 30, 2021 | 10.86 |
| March 31, 2021 | -9.902 |
| December 31, 2020 | -13.36 |
| September 30, 2020 | -14.91 |
| June 30, 2020 | -18.90 |
| March 31, 2020 | -15.69 |
| December 31, 2019 | -12.27 |
| September 30, 2019 | -12.29 |
| June 30, 2019 | -11.65 |
| March 31, 2019 | -18.93 |
| December 31, 2018 | -9.226 |
| March 31, 2018 | -5.384 |
| December 31, 2017 | -4.410 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Editas Medicine, Inc. | -0.2552 |
| AnaptysBio, Inc. | -1.843 |
| 4D Molecular Therapeutics, Inc. | -1.010 |
| Agenus, Inc. | 1.023 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.44M |
| Revenue (Quarterly) | 10.84M |
| Total Expenses (Quarterly) | 29.28M |
| Enterprise Value | 115.41M |
| Gross Profit Margin (Quarterly) | 94.09% |
| Profit Margin (Quarterly) | -170.2% |
| Earnings Yield | -50.97% |
| Normalized Earnings Yield | -50.65 |